Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biora Therapeutics is a clinical-stage biotechnology company focused on creating smart pills for targeted drug delivery and needle-free oral delivery of large molecules. The company's NaviCap platform is designed for site-specific delivery of therapeutics directly to the gastrointestinal tract to improve outcomes for patients with inflammatory bowel disease. Additionally, its BioJet platform aims to replace injections by using an ingestible capsule that delivers biologics into the small intestine wall for systemic absorption. Formerly known as Progenity, the company pivoted from molecular testing to focus entirely on its innovative drug delivery technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biora Manufacturing.